Anti-GPRC5D Antibody for Cancer Treatment
Summary
The USPTO has published a patent application (US20260085114A1) filed by Kyinno Biotechnology Co., Ltd. The application describes an anti-G protein-coupled receptor family class C group 5 member D (GPRC5D) antibody or fragment thereof for the treatment of tumors or cancers. It also details a bispecific antibody targeting GPRC5D and CD3.
What changed
This document is a publication of a patent application filed by Kyinno Biotechnology Co., Ltd. The application, identified as US20260085114A1, details an antibody or antibody fragment targeting GPRC5D, intended for the treatment of tumors and cancers. It also describes a bispecific antibody that targets both GPRC5D and CD3.
As this is a patent application, it does not impose immediate regulatory obligations on companies. However, it signifies potential future developments in cancer therapeutics and may be relevant for companies operating in the oncology and biotechnology sectors for competitive intelligence and intellectual property landscape monitoring.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-GPRC5D ANTIBODY AND USE THEREOF
Application US20260085114A1 Kind: A1 Mar 26, 2026
Assignee
Kyinno Biotechnology Co., Ltd.
Inventors
Jinying Ning, Hao Peng, Feng Hao, Feng He
Abstract
Provided is an anti-G protein-coupled receptor family class C group 5 member D (GPRC5D) antibody or a fragment thereof. Also provided is the use of the antibody or fragment thereof as an active ingredient for treatment of tumors or cancers. In addition, further provided is a bispecific antibody comprising the antibody or fragment thereof and aiming at GPRC5D and CD3.
CPC Classifications
C07K 16/2809 A61K 38/00 A61P 35/00 C12N 15/11 C07K 2317/24 C07K 2317/31 C07K 2317/51 C07K 2317/515 C07K 2317/522 C07K 2317/524 C07K 2317/526 C07K 2317/565 C07K 2317/732 C07K 2317/92
Filing Date
2022-12-28
Application No.
18725510
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.